Logo

SEED

Origin Agritech Limited

SEED

Origin Agritech Limited • NASDAQ
$1.40 ▼ -4.11% (-0.06)
Market Cap $9.66 M
52w High $2.75
52w Low $0.74
Dividend Yield 0%
P/E -17.5
Volume 7.96K
Outstanding Shares 6.90M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2025 $36.17M $16.386M $-12.792M -35.366% $-1.78 $-11.644M
Q1-2025 $36.17M ▲ $16.386M ▼ $-12.792M ▼ -35.366% ▼ $-1.78 ▼ $-11.644M ▲
Q4-2024 $10.671M $19.612M $9.679M 90.704% $1.46 $-19.602M ▼
Q3-2024 $10.671M ▼ $19.612M ▲ $9.679M ▲ 90.704% ▲ $1.46 ▲ $-19.309M ▼
Q2-2024 $46.02M $6.721M $677.5K 1.472% $0.11 $3.139M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2025 $2.4M $88.711M $151.359M $-31.158M
Q1-2025 $2.4M ▼ $88.711M ▼ $151.359M ▼ $-31.158M ▲
Q4-2024 $8.375M $131.562M $190.161M $-31.291M
Q3-2024 $8.375M ▼ $131.562M ▼ $190.161M ▼ $-31.291M ▲
Q2-2024 $10.416M $223.415M $299.775M $-55.939M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $-12.792M $-5.886M $-2.071M $5.117M $0 $-7.957M
Q1-2025 $-12.792M ▼ $-5.886M ▼ $-2.071M ▼ $5.117M ▲ $0 $-7.957M ▼
Q4-2024 $9.678M $-1.468M $-1.994M $2.408M $0 ▲ $-3.462M
Q3-2024 $9.678M ▲ $-1.468M ▲ $-1.994M ▼ $2.408M ▲ $-10.416M ▲ $-3.462M ▲
Q2-2024 $1.359M $-12.13M $-986.916K $-318.944K $-13.048M $-13.117M

Five-Year Company Overview

Income Statement

Income Statement Revenue has been inching up over the past few years but still sits at a very small scale, more like an R&D-heavy specialty company than a mature agricultural supplier. Gross profit has been fairly steady, suggesting the core products that do sell can carry reasonable margins. However, operating income has stayed in the red, which means the core business is not yet covering its research, overhead, and selling costs. Recent positive net income seems to be driven by non-operating or one‑off items rather than a fully profitable day‑to‑day business. Overall, the income statement tells a story of early-stage commercialization with promising technology but a business model that is not yet financially stable on its own.

Balance Sheet

Balance Sheet The balance sheet is small and still fragile. Total assets are modest, cash levels are thin, and shareholders’ equity remains negative, which reflects a long history of accumulated losses. On the positive side, debt has been reduced sharply compared with a few years ago, lowering financial leverage and interest burden. Even so, negative equity and limited cash leave little cushion against operational setbacks or delays in commercialization. The company looks more like a high‑risk technology platform than a well-capitalized industrial player at this stage.

Cash Flow

Cash Flow Cash flow from operations has hovered around break-even but generally negative, meaning the business is consuming cash rather than generating it. Free cash flow has also been negative in most years, even with relatively light spending on equipment and facilities. This suggests the company still relies on external funding or special gains to support its activities rather than self-funding from its own operations. The pattern is typical for an innovation-heavy company before full commercial scale, but it also highlights ongoing liquidity and execution risk if commercialization is slower than hoped.

Competitive Edge

Competitive Edge Technologically, the company appears to punch above its weight. It holds a rare position in China with triple‑stack trait corn and advanced gene‑edited traits, areas where local competition is still limited. Long-standing collaborations with major universities and regional seed companies, plus a deep genetic library, create a real barrier to entry for newcomers. At the same time, its tiny revenue base and weak balance sheet mean it competes from a financially thin position against global seed majors and well-funded domestic players. The company’s moat is primarily scientific and regulatory-first-mover, not yet commercial scale or brand strength.

Innovation and R&D

Innovation and R&D Innovation is the clear centerpiece here. The company is deeply involved in GMO and gene‑editing work, with traits targeting insect resistance, herbicide tolerance, drought resilience, plant architecture, nitrogen efficiency, and nutritional enhancement. Shortening breeding cycles dramatically and achieving publication in top scientific journals indicate strong technical credibility. A pipeline of next‑generation traits and gene‑edited corn, along with a service platform to help others commercialize biotech seeds, gives multiple potential revenue avenues. The main uncertainty is timing and scale: turning this rich R&D portfolio into broad, recurring sales in a still-evolving regulatory and market environment in China.

Summary

Overall, SEED looks like a science-driven agricultural technology company that is still in the transition from lab success to commercial scale. The financials show small but growing revenue, persistent operating losses, negative equity, and reliance on external or non-core sources to reach profitability. By contrast, its innovation and regulatory positioning in China’s GMO and gene‑editing space appear strong and differentiated, backed by partnerships and a large germplasm base. The opportunity is that wider GMO acceptance and successful commercialization could significantly reshape its financial picture. The risk is that delays, regulatory changes, or competitive pushback could strain a fragile balance sheet and limited cash before the technology fully pays off.

NEWS

November 10, 2025 · 7:00 AM UTC

Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech

Read more

October 24, 2025 · 7:00 AM UTC

Origin Agritech Obtains New Licenses for Crop Seed Production and GMO Business Operations

Read more

October 15, 2025 · 7:00 AM UTC

Origin Agritech Executes Northeast China Market Re-Entry with Product Showcase and Technology Seminar

Read more

September 30, 2025 · 7:30 AM UTC

Origin Agritech Announces Investment Agreements, Including Investment from Origin CEO Weibin Yan

Read more

September 12, 2025 · 7:30 AM UTC

Origin Agritech Announces Appointment of Two New Independent Directors and Board Restructuring

Read more